Virtual Environment Training in the Proper Use of Prescription Pain Medications

描述：(申请人提供)目前，处方止痛药成瘾的流行导致的死亡人数超过了与汽车相关的死亡人数，入院人数上升，并扰乱了患者和家人的生活。白宫国家药物管制政策办公室(ONDCP)的报告《流行病：应对美国的处方药滥用危机》强调了这一危机，并呼吁医疗保健专业教育正确使用阿片类药物；与阿片类止痛药相关的必要教育似乎是不可避免的。预期影响：该项目通过以下方式响应这一号召：1)使用具有虚拟患者场景的在线互动虚拟环境(OLIVE)创建持续健康专业发展(CHPD)计划，以及2)评估产品改变提供者行为的能力，以减少处方阿片类药物的流行。新产品将是现有的、成功的OpioidRisk.com的一部分，该网站是在NIDA合同的支持下开发的，并通过药物滥用医学教育协会(AMERSA)和临床工具公司之间的合作伙伴关系生产。我们希望：“提供者将提高他们的临床技能，并通过OLIVE的模拟(即计算机生成)患者的刻意练习来测试实践变化。计划中的计划将测试他们的技能，并提供自动反馈、指导和指导。“临床领导和卫生保健组织可以实施一项全面的慢性阻塞性肺病计划。”卫生专业教育社区将获得有关新型虚拟环境技术在灌输新的行为和影响实践改变方面的潜力的重要数据。第一阶段通过以下方式证明了产品的可行性和继续进行第二阶段工作的可接受性：1)完成目标受众需求分析调查和半结构化访谈；2)为基于橄榄的慢性阻塞性肺病培训创建关于阿片类药物正确使用的培训框架；3)概述将用于橄榄与基于网络的培训的评估；4)开发原型橄榄培训体验；和5)展示可接受性和可行性，并为第二阶段研究招募诊所地点。第二阶段根据我们以前开发的产品(OpiodRisk.com)的交互式案例教学、临床问题、资源和实施指南中已经找到的内容来完成该计划。在最终确定终结性研究的临床参与后，该项目使用基于橄榄的培训与OpioidRisk.com的随机主动对照设计来评估CHPD计划，该设计比较了能力、表现、临床和沟通技能的变化，以及与阿片类药物处方和疼痛患者成瘾风险评估相关的改善的治疗行为。

DESCRIPTION: (provided by applicant) An epidemic of addiction to prescription pain medications now causes deaths due to overdose that outnumber automobile-related deaths, rising admissions to hospitals, and disrupted lives for both the patient and family. The White House Office of National Drug Control Policy (ONDCP) report, Epidemic: Responding to America's Prescription Drug Abuse Crisis, highlights the crisis and calls for health care professional education in the proper use of opioids; required education related to opioid pain medications appears inevitable. Intended Impact: This project responds to this call by: 1) creating a continuing health professional development (CHPD) program using an On-Line Interactive Virtual Environment (OLIVE) with virtual patient scenarios, and 2) evaluating the products' ability to alter provider behavior relevant to decreasing the prescription opioid epidemic. The new product will be a part of the existing, successful OpioidRisk.com, which was developed with support from a NIDA contract, and is produced via a partnership between the Association for Medical Education on Substance Abuse (AMERSA) and Clinical Tools. We expect:" Providers will enhance their clinical skills and test practice change through deliberate practice via OLIVE's simulated (i.e., computer-generated) patients. The planned program will test their skills and provide automated feedback, guidance and direction. "Clinic leaders and health care organizations can implement a comprehensive CHPD program."The health professional education community will gain important data regarding the potential of novel virtual environment technology to instill new behaviors and effect practice change. Phase I demonstrates product feasibility and the acceptability of proceeding with Phase II by: 1) completing target audience needs analysis surveys and semi-structured interviews; 2) creating a training framework for OLIVE-based CHPD training on the proper use of opioids; 3) outlining assessments to be used in the Phase II evaluative study of OLIVE vs. web-based training; 4) developing a prototype OLIVE training experience; and, 5) demonstrating acceptability and feasibility and recruiting clinic locations for the Phase II study. Phase II completes the program based on content already found in our previously developed product's (OpiodRisk.com) interactive case-based instruction, clinical questions, resources and implementation guides. After finalizing clinic participation for the summative study, the project evaluates the CHPD program using a randomized, active control design of OLIVE-based training vs. OpioidRisk.com that compares change in competency, performance, clinical, and communication skills and improved treatment behavior related to opioid prescribing and pain patient assessment for addiction risk.